Lysosomal acid glucosylceramidase
| GO Term | Evidence Code | Reference |
|---|---|---|
| mitophagy |
|
|
| glucosylceramide catabolic process | ||
| glucosylceramide catabolic process | ||
| glucosylceramide catabolic process | ||
| glucosylceramide catabolic process |
| GO Term | Evidence Code | Reference |
|---|---|---|
| lysosome | ||
| lysosome | ||
| lysosomal membrane | ||
| lysosomal membrane | ||
| lysosomal membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| galactosylceramidase activity | ||
| glucosylceramidase activity | ||
| glucosylceramidase activity | ||
| glucosylceramidase activity | ||
| glucosylceramidase activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 58 |
|
|||
| 60 |
|
|
||
| 98 |
|
|||
| 185 |
|
|||
| 187 |
|
|||
| 309 |
|
|||
| 310 |
|
|||
| 501 |
|
|
| Pathway Name | Organism |
|---|---|
| Association of TriC/CCT with target proteins during biosynthesis | Homo sapiens |
| Glycosphingolipid catabolism | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:12217 | Lewy body dementia | |
| DOID:0112250 | Gaucher's disease type IIIC | |
| DOID:0080855 | Parkinsonism | |
| DOID:1926 | Gaucher's disease | |
| DOID:14330 | Parkinson's disease | |
| DOID:0110960 | Gaucher's disease perinatal lethal | |
| DOID:0110957 | Gaucher's disease type I | |
| DOID:0110958 | Gaucher's disease type II | |
| DOID:0060892 | late onset Parkinson's disease | |
| DOID:0110959 | Gaucher's disease type III |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026